Navigation Links
Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients
Date:10/18/2010

the role fenretinide may play in treating our patients."

The double-masked, placebo-controlled, multicenter, Phase 2b study evaluated 246 patients with GA. Patients were randomized into three cohorts and received once-daily, oral doses of 100 mg or 300 mg of fenretinide or placebo for 24 months. Retinal lesion size was measured by color fundus photography, fundus autofluorescence and fluorescein angiography. Patients were also evaluated by contrast sensitivity, reading rate, visual acuity, optical coherence tomography, the incidence of choroidal neovascularization (CNV) and serum RBP levels. This is the largest study to date for an oral therapeutic agent for treatment of GA. Fenretinide was well tolerated with no severe drug-related adverse events and no significant effects on normal visual function.

Analysis of the lesion and RBP data at the conclusion of the two-year study showed that 43 percent of patients in the 300 mg fenretinide arm had a sustained RBP reduction of at least 60 percent throughout the trial. Those patients had a median lesion size growth of only 30 percent from baseline, compared to a median lesion size growth of about 50 percent in the placebo arm. Visual acuity loss in patients who experienced reduced lesion size growth was stabilized from 12 months to 24 months at six letters lost, while patients in the placebo arm showed progressive loss throughout the trial reaching an average loss of 11 letters at 24 months.

At the conclusion of the two-year study, the incidence of CNV in the placebo arm was 22 percent. Meanwhile, CNV incidence in patients receiving either dose of fenretinide was ~13 percent to 14 percent. The comparable therapeutic effect at both low and high doses of fenretinide suggests a mechanism of action that is not dependent upon reduction of serum RBP.

The accumulation of retinol (vitamin A)-derived toxins in the eye is believed to exacerbate lesion growth leading to progression of GA. Inflammation a
'/>"/>

SOURCE ReVision Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kaiser Permanentes ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health
2. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
3. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
4. Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
5. DATATRAK Awarded Three Phase III Studies
6. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
7. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
8. Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study
9. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
10. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
11. Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... , ... Netherlands , January 12 QIAGEN N.V.,(NASDAQ: QGEN ; ... GmbH, a privately held developer and manufacturer of UV and,fluorescence optical measurement ... at up to US$19 million in cash. , ...
... , MINNEAPOLIS, Jan. 11 ATS Medical, Inc. (Nasdaq: ... and services today announced preliminary fourth quarter 2009 revenue and ... Medical,s President and Chief Executive Officer, Michael Dale, at the ... 2010, in San Francisco, CA, at 8 a.m. Pacific Time ...
Cached Medicine Technology:QIAGEN Acquires ESE GmbH 2QIAGEN Acquires ESE GmbH 3QIAGEN Acquires ESE GmbH 4QIAGEN Acquires ESE GmbH 5QIAGEN Acquires ESE GmbH 6QIAGEN Acquires ESE GmbH 7ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 30, 2014 Developed as a nod ... quality Canada Goose products offer the mobility, ... on Arctic runways. The company’s Canada Goose Chilliwack ... the current market. Additionally, the firm has unveiled its ... , At present, all high quality Chilliwack bombers ...
(Date:8/29/2014)... 29, 2014 As reported by GantDaily.com in ... Drug Abuse Trends , Outbreaks (8/20), the National Institute on ... monitor drug abuse trends by turning to social media. As ... trends, it is also working with the University of Maryland ... Early Warning System, which will be funded by the National ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Formed in 2014, ... talents well beyond their years. Their sophisticated Pop/R&B sound, ... music listener is fortunate enough to experience every day. ... their audience uplifted and feeling loved with the primary purpose ... specifically about this, the group unanimously replied - “To make ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... to Chapman University Physical Therapy students via Clinical ... Chapman University will be shadowing Healthpointe providers and ... allow them to develop clinical experience and learn ... Therapy students will gain insight into several patient ...
Breaking Medicine News(10 mins):Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2
... viruses due to their protective protein cover which protects them. ... //. ,Tackling this problem, scientists at the Institut ... the European Molecular Biology Laboratory (EMBL) in Grenoble have found ... a protein that allows the rabies virus to be harmful ...
... Australian beauty with roots in India open to acting in ... in India// who will represent Australia in the Miss World ... ,The first person of non-Australian parentage to win the ... an Indian mother and a Lebanese father. ,Sabrina, ...
... of Union Health Minister Anbumani Ramdoss, a pro-reservation ... P Venugopal and some senior doctors for allegedly ... Delhi against reservations for OBCs in higher education. ... members of the institution instigated the anti-quota protests ...
... According to a finding published in the medical journal Pediatrics, ... to guard// against chicken pox spurt in schools. ,Dr. ... Health conducted a study during an outbreak of chicken pox ... the 545 children attending the school had not suffered chicken ...
... in place of regular salt in everyday diet could ... , high blood pressure and diabetes, a study has ... Institutes in Taiwan and fellow researchers studied nearly 2,000 ... ,The researchers asked cooks at the retirement home to ...
... Swaraj today expressed concern over the turf war between Union ... saying it could "destroy the premier institution". ,"I am ... institution is being destroyed by the present union minister," she ... are working there and it is churning out the best ...
Cached Medicine News:
... QC 463 is a quality control ... monitoring the performance of blood gas, electrolyte, ... practical alternative to the use of human ... in three (3) levels for monitoring analyzer ...
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... way to capture and process ultrasound images, ... a revolutionary advancement. The z.one platform, powered ... Convertible Ultrasound system, instantly converting from a ... ultrasound system with all the performance of ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: